Ursodeoxycholic acid attenuates hepatotoxicity of multidrug treatment of mycobacterial infections: A prospective pilot study

Background: Tuberculosis (TB) remains a global health problem. The application of rifampicin-based regimens for antimycobacterial therapy is hampered by its marked hepatotoxicity which results in poor adherence and may contribute to prolonged therapy or treatment failure. The purpose of this prospec...

Full description

Bibliographic Details
Main Authors: Susanne M Lang, Johannes Ortmann, Sven Rostig, Helmut Schiffl
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:International Journal of Mycobacteriology
Subjects:
Online Access:http://www.ijmyco.org/article.asp?issn=2212-5531;year=2019;volume=8;issue=1;spage=89;epage=92;aulast=Lang